Work

Talimogene laherparepvec (T-VEC) as cancer immunotherapy

Year: 2015

Type: article

Source: Drugs of today

DOI: 10.1358/dot.2015.51.9.2383044

Authors: F.J. Kohlhapp, A. Zloza, H.L. Kaufman

Institution: Rutgers Cancer Institute

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2180157871

FWCI: 2.731

Cites:

Cited by: 42

Related to: 10